Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details 1)

v3.3.0.814
Summary of Significant Accounting Policies (Details 1) - shares
 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Schedule of antidilutive securities excluded from computation of earnings per share    
Antidilutive securities excluded from computation of earnings per share, Amount 11,595,474 4,858,836 [1]
Preferred Stock Series B    
Schedule of antidilutive securities excluded from computation of earnings per share    
Antidilutive securities excluded from computation of earnings per share, Amount 2,700,000
Warrants    
Schedule of antidilutive securities excluded from computation of earnings per share    
Antidilutive securities excluded from computation of earnings per share, Amount 7,936,391 933,617
Options    
Schedule of antidilutive securities excluded from computation of earnings per share    
Antidilutive securities excluded from computation of earnings per share, Amount 3,659,083 1,225,219
[1] September 30, 2014, excludes the impact of Put agreements, which subscribed certain shareholders of the Company to purchase additional shares and warrants contingent upon, and concurrently with, completion of the IPO.